PrEP

A survey spanning almost two decades shows a consistent increase in condom-less anal sex and number of sexual partners in MSM as many see antiretroviral therapy as a "protective back-up" measure to avoid HIV infection.

Researchers have found incidence of multidrug-resistant HIV-1 infection, despite the use of preexposure prophylaxis (PrEP).

Researchers from the University of Pennsylvania Perelman School of Medicine show that many young transgender women are aware of HIV PrEP and have positive attitudes toward it.

UCLA researchers have developed an online risk assessment calculator that will allow individuals to check their “PrEP score.”

Drug “buyers clubs” that include websites such as PrEPster and I Want PrEP Now are providing a number of at-risk individuals living in the United Kingdom with HIV drugs that can potentially save their lives.

We’ve put together the top five biggest news stories on HIV Contagion covered this year. Did you read them all?

The first large-scale clinical trial of a new HIV preventive drug, cabotegravir, has been launched and researchers are looking to see if it is just as effective as Truvada, the only licensed PrEP regimen currently available.

Aggressive and earlier treatments can forestall new HIV infections, but how much are we willing to spend?

California health officials’ “Getting to Zero” plan aims to dramatically cut the number of HIV cases in California through increased surveillance, access to care, and treatment.

The National Institute of Mental Health has granted researchers at the University of Pennsylvania School of Nursing and New York Blood Center $769,578 to go towards efforts to create an HIV awareness program for women.

Buyers clubs are still going strong in the United States and around the world as the offer a low-cost alternative for individuals with HIV and hepatitis c virus (HCV) who often find themselves struggling to pay for the expensive medications they need to treat their illness.

At the Centers for Disease Control and Prevention's 2016 STD Prevention Conference, researchers discussed three novel prevention strategies for HIV, other STIs, and unintended pregnancies.

Technology gives men who have sex with men (MSM) new ways to assess their health status, prevent HIV and other STDs (sexually transmitted diseases), and find care.

New prevention and treatment models are needed worldwide and one such model is the Dean Street Express Clinic in London, England.

A new test that can effectively estimate HIV-negative patients’ adherence to prescribed drugs to prevent the transmission of human immunodeficiency virus (HIV) during sexual intercourse has been discovered by researchers at the Skaggs School of Pharmacy and Pharmaceutical Sciences at CU Anschutz.

David Rosenthal, DO, PhD, medical director at the Center for Young Adult, Adolescent and Pediatric HIV Care at Northwell Health, reflects on a JAMA study, which states that use of antiretroviral therapy reduced the risk of HIV transmission during condomless sex.

The number of physicians and nurse practitioners aware of HIV pre-exposure prophylaxis (PrEP) and its potential benefits has increased dramatically in the years since it was first introduced to the market.

This article seeks to review newer ART agents, as well as those in later stages of drug development, for the treatment of HIV-1 infection.